Cargando…
Clinicopathological features of superficial CD34-positive fibroblastic tumor
BACKGROUND: Superficial CD34-positive fibroblastoma (SCPFT) is a newly discovered mesenchymal tumor characterized by high polymorphism, low mitotic rate, and diffuse CD34-positive reactions. AIM: To further determine the clinicopathological features of SCPFT. METHODS: We retrospectively analyzed the...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058686/ https://www.ncbi.nlm.nih.gov/pubmed/33969057 http://dx.doi.org/10.12998/wjcc.v9.i12.2739 |
_version_ | 1783681060605788160 |
---|---|
author | Ding, Li Xu, Wen-Jing Tao, Xiao-Ying Zhang, Liang Cai, Zhao-Gen |
author_facet | Ding, Li Xu, Wen-Jing Tao, Xiao-Ying Zhang, Liang Cai, Zhao-Gen |
author_sort | Ding, Li |
collection | PubMed |
description | BACKGROUND: Superficial CD34-positive fibroblastoma (SCPFT) is a newly discovered mesenchymal tumor characterized by high polymorphism, low mitotic rate, and diffuse CD34-positive reactions. AIM: To further determine the clinicopathological features of SCPFT. METHODS: We retrospectively analyzed the clinicopathological data, immunohistochemistry results, and differential diagnoses of four patients with SCPFT and performed a literature review. Relevant fusion genes were also detected. RESULTS: The tumors were all located in the lower extremities and presented as slow-growing painless masses located in the dermis and subcutaneous tissue. Microscopically, the tumors were composed of spindle-shaped to epithelioid cells with scattered abnormal and pleomorphic nuclei on a fibrous or fibromyxoid background. Necrosis was not found in the tumor tissues, and mitotic figures were rare. Immunohistochemically, the tumor cells were strongly positive for vimentin and CD34, and CKpan showed focal positivity in two tumors. All four patients were followed (13-57 mo, mean 35 mo), and one patient experienced local recurrence. CONCLUSION: SCPFT is a newly discovered borderline mesenchymal tumor that can locally recur or even metastasize. Familiarity with its clinicopathological features will help avoid confusion with skin mesenchymal tumors with similar features. |
format | Online Article Text |
id | pubmed-8058686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-80586862021-05-06 Clinicopathological features of superficial CD34-positive fibroblastic tumor Ding, Li Xu, Wen-Jing Tao, Xiao-Ying Zhang, Liang Cai, Zhao-Gen World J Clin Cases Retrospective Study BACKGROUND: Superficial CD34-positive fibroblastoma (SCPFT) is a newly discovered mesenchymal tumor characterized by high polymorphism, low mitotic rate, and diffuse CD34-positive reactions. AIM: To further determine the clinicopathological features of SCPFT. METHODS: We retrospectively analyzed the clinicopathological data, immunohistochemistry results, and differential diagnoses of four patients with SCPFT and performed a literature review. Relevant fusion genes were also detected. RESULTS: The tumors were all located in the lower extremities and presented as slow-growing painless masses located in the dermis and subcutaneous tissue. Microscopically, the tumors were composed of spindle-shaped to epithelioid cells with scattered abnormal and pleomorphic nuclei on a fibrous or fibromyxoid background. Necrosis was not found in the tumor tissues, and mitotic figures were rare. Immunohistochemically, the tumor cells were strongly positive for vimentin and CD34, and CKpan showed focal positivity in two tumors. All four patients were followed (13-57 mo, mean 35 mo), and one patient experienced local recurrence. CONCLUSION: SCPFT is a newly discovered borderline mesenchymal tumor that can locally recur or even metastasize. Familiarity with its clinicopathological features will help avoid confusion with skin mesenchymal tumors with similar features. Baishideng Publishing Group Inc 2021-04-26 2021-04-26 /pmc/articles/PMC8058686/ /pubmed/33969057 http://dx.doi.org/10.12998/wjcc.v9.i12.2739 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Ding, Li Xu, Wen-Jing Tao, Xiao-Ying Zhang, Liang Cai, Zhao-Gen Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title | Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title_full | Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title_fullStr | Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title_full_unstemmed | Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title_short | Clinicopathological features of superficial CD34-positive fibroblastic tumor |
title_sort | clinicopathological features of superficial cd34-positive fibroblastic tumor |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058686/ https://www.ncbi.nlm.nih.gov/pubmed/33969057 http://dx.doi.org/10.12998/wjcc.v9.i12.2739 |
work_keys_str_mv | AT dingli clinicopathologicalfeaturesofsuperficialcd34positivefibroblastictumor AT xuwenjing clinicopathologicalfeaturesofsuperficialcd34positivefibroblastictumor AT taoxiaoying clinicopathologicalfeaturesofsuperficialcd34positivefibroblastictumor AT zhangliang clinicopathologicalfeaturesofsuperficialcd34positivefibroblastictumor AT caizhaogen clinicopathologicalfeaturesofsuperficialcd34positivefibroblastictumor |